GAUDIO, AGOSTINO
 Distribuzione geografica
Continente #
EU - Europa 3.215
NA - Nord America 2.578
AS - Asia 1.521
SA - Sud America 438
Continente sconosciuto - Info sul continente non disponibili 92
AF - Africa 46
OC - Oceania 6
Totale 7.896
Nazione #
US - Stati Uniti d'America 2.509
RU - Federazione Russa 1.760
SG - Singapore 615
CN - Cina 484
BR - Brasile 362
IE - Irlanda 319
SE - Svezia 307
DE - Germania 262
HK - Hong Kong 171
IT - Italia 144
FI - Finlandia 109
FR - Francia 101
VN - Vietnam 93
UA - Ucraina 63
GB - Regno Unito 59
IN - India 49
CA - Canada 27
PL - Polonia 24
AR - Argentina 21
BD - Bangladesh 18
MX - Messico 18
TR - Turchia 16
VE - Venezuela 16
BE - Belgio 15
ES - Italia 15
ZA - Sudafrica 14
IQ - Iraq 13
CO - Colombia 9
AT - Austria 8
JP - Giappone 8
MA - Marocco 8
NL - Olanda 8
CL - Cile 7
PK - Pakistan 7
PY - Paraguay 7
AU - Australia 6
CZ - Repubblica Ceca 6
MY - Malesia 6
CI - Costa d'Avorio 5
EC - Ecuador 5
HN - Honduras 5
ID - Indonesia 5
PE - Perù 5
KE - Kenya 4
LT - Lituania 4
NI - Nicaragua 4
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EE - Estonia 3
EG - Egitto 3
GE - Georgia 3
GT - Guatemala 3
IR - Iran 3
JM - Giamaica 3
KG - Kirghizistan 3
KR - Corea 3
OM - Oman 3
PH - Filippine 3
PT - Portogallo 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
JO - Giordania 2
NG - Nigeria 2
NP - Nepal 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TW - Taiwan 2
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
HU - Ungheria 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
MN - Mongolia 1
PS - Palestinian Territory 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 7.804
Città #
Moscow 470
Ashburn 399
Singapore 319
Dublin 318
Chandler 238
Dallas 238
San Jose 184
Nyköping 171
Beijing 155
Jacksonville 147
Munich 147
Hong Kong 145
The Dalles 81
New York 73
Council Bluffs 71
Helsinki 62
Los Angeles 56
Lauterbourg 50
Princeton 46
Messina 45
Medford 43
Ann Arbor 37
Ho Chi Minh City 36
Dearborn 34
São Paulo 33
Des Moines 31
Cambridge 30
Santa Clara 30
Boardman 29
Bremen 29
Buffalo 24
Shenyang 22
Tianjin 21
Frankfurt am Main 19
Guangzhou 19
Warsaw 19
Hanoi 18
Brussels 15
Houston 15
Jinan 15
Nanjing 15
Turku 15
Orem 14
Redondo Beach 14
Belo Horizonte 12
Pune 12
Seattle 12
Wilmington 12
Catania 11
Düsseldorf 11
Johannesburg 11
Brooklyn 10
Chennai 10
Atlanta 9
Montreal 9
San Mateo 9
Boston 8
Columbus 8
Hebei 8
Lancaster 8
Manchester 8
Mumbai 8
Central 7
Denver 7
Mexico City 7
Nuremberg 7
Poplar 7
Shanghai 7
Sheung Shui 7
Strasbourg 7
Tokyo 7
Ankara 6
Falls Church 6
Hangzhou 6
Taiyuan 6
Woodbridge 6
Zhengzhou 6
Abidjan 5
Brno 5
Da Nang 5
Fuzhou 5
Haikou 5
Porto Alegre 5
Rio de Janeiro 5
San Francisco 5
Santiago 5
Shenzhen 5
Baghdad 4
Bauru 4
Brasília 4
Chicago 4
Goiânia 4
Kuala Lumpur 4
Lahore 4
Lappeenranta 4
Lima 4
London 4
Melbourne 4
Nairobi 4
Nanchang 4
Totale 4.369
Nome #
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 298
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 244
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 228
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 224
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 224
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 197
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 194
ALENDRONATE TAIL EFFECT ON BONE IS MODULATED BY VITAMIN D: A RETROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 191
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 185
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 185
Anxiety levels predict bone mineral density in postmenopausal women undergoing oral bisphosphonates: A two-year follow-up 184
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 181
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 178
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 176
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 174
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 170
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 168
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 166
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 161
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 160
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 154
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 150
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 148
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 145
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 143
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: New pieces of the puzzle 143
CORRELATION BETWEEN FAMILY HISTORY OF HYPERTENSION AND HAEMOSTATIC DISORDERS 142
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 142
Early vascular ageing biomarkers in osteoporotic outpatients: a pilot study 142
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 141
Renal function is associated with changes in bone mineral density in postmenopausal osteoporotic women treated with Denosumab: data from a retrospective cohort study 137
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 137
Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors 133
HANDGRIP STRENGTH TO DISCRIMINATE HIGH FRACTURE RISK IN TYPE 2 DIABETES MELLITUS PATIENTS 133
Effetti del raloxifene sulla secrezione ipofisaria in post-menopausa 132
Clinical and molecular description of the first Italian cohort of 33 subjects with hypophosphatasia 131
Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D 128
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 125
Sclerostin is a possible candidate marker of arterial stiffness: Results from a cohort study in Catania 124
Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major 112
VITAMIN D PROMOTES BONE MINERAL DENSITY ACCRUAL AFTER DISCONTINUATION OF ALENDRONATE 112
Pharmacological management of severe postmenopausal osteoporosis 108
Familiar osteopoikilosis: Case report with differential diagnosis and review of the literature 107
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 101
Pathogenesis of Thalassemia Major-Associated Osteoporosis: Review of the Literature and Our Experience 101
Menopause modulates homocysteine levels in diabetic and non-diabetic women. 98
Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women 88
Calf circumference predicts changes of bone mineral density in postmenopausal osteoporotic women receiving denosumab 87
POS1119 A SINGLE DOSE OF ZOLEDRONATE INDUCES MODIFICATIONS OF SERUM VEGF IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN 84
Exploring the Association Between Platelet Count, the Systemic Immune Inflammation Index, and Fracture Risk in Postmenopausal Women with Osteoporosis: A Cross-Sectional Study 78
Quantitative ultrasound and DXA measurements in aromatase inhibitor-treated breast cancer women receiving denosumab 78
IMPACT OF ANXIETY LEVELS ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN TREATED WITH ORAL BIPHOSPHONATES: RESULTS FROM A LONGITUDINAL COHORT STUDY 75
Pain in Osteoporosis: Current and Future Strategies 73
Osteoporosis and Fragility Fractures in Type 2 Diabetes 31
null 21
null 21
Association of Mediterranean Diet Adherence with Self-Reported Muscle-Related Functional Status and Fracture Probability in Postmenopausal Women Evaluated for Osteoporosis: A Cross-Sectional Study 3
Totale 7.896
Categoria #
all - tutte 25.733
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.733


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022413 0 63 14 7 14 6 48 12 32 76 36 105
2022/2023945 62 110 51 53 79 94 10 63 376 12 21 14
2023/2024299 20 39 15 28 14 81 4 39 0 11 14 34
2024/20251.305 29 21 17 83 56 81 75 219 314 91 119 200
2025/20264.003 212 261 244 243 333 816 457 572 567 156 58 84
2026/2027265 71 194 0 0 0 0 0 0 0 0 0 0
Totale 7.896